SCHEMBL22693186

SCHEMBL22693186

Cc1ccc(C#N)c(N2CCC(Nc3cc(C(=O)N4CCN(c5cccnc5S(N)(=O)=O)CC4)c(C)cc3C(F)(F)F)CC2)c1

nearest known ligand 0.60

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MTOR P42345 8/20 0.60
RPTOR Q8N122 8/20 0.60
MLST8 Q9BVC4 8/20 0.60
NPSR1 Q6W5P4 1/20 0.38
SYK P43405 2/20 0.37
FFAR1 O14842 1/20 0.36
AR P10275 1/20 0.36
KDM4E B2RXH2 1/20 0.35
LMNA P02545 1/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA9 Q16790 1/20 0.35
PRKCQ Q04759 2/20 0.35
PRKCD Q05655 2/20 0.35
POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20133722 0.94 MTOR (0.68) MTORRPTORMLST8NPSR1SYK
SCHEMBL20129697 0.86 MTOR (0.75) MTORRPTORMLST8SYKKDM4E
SCHEMBL20133708 0.82 MTOR (0.58) MTORRPTORMLST8SYKAR
SCHEMBL20149908 0.82 MTOR (0.56) MTORRPTORMLST8NPSR1SYK
SCHEMBL22188026 0.82 MTOR (0.58) MTORRPTORMLST8ARPRKCQ
SCHEMBL20133763 0.77 MTOR (0.80) MTORRPTORMLST8SYKKDM4E
SCHEMBL21360324 0.77 MTOR (0.76) MTORRPTORMLST8NPSR1KDM4E
SCHEMBL20133689 0.76 MTOR (1.00) MTORRPTORMLST8KDM4ECA12
SCHEMBL20133721 0.75 MTOR (0.56) MTORRPTORMLST8ARKDM4E
SCHEMBL20133670 0.74 MTOR (0.69) MTORRPTORMLST8LMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10844013-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof NAVITOR PHARMACEUTICALS, INC. (US) 2020-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10844013-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof MTOR, RICTOR, RPTOR MTOR 1/4885RPTOR 3/4885MLST8 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.